Literature DB >> 17720742

Comparison of time trends in prostate cancer incidence (1973 1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV VIII.

Tomohiro Matsuda1, Kumiko Saika.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17720742     DOI： 10.1093/jjco/hym100

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  8 in total

1.  Transition zone prostate specific antigen density improves prostate cancer detection in Iranian men.

Authors:  Mohammadreza Nowroozi; Mohsen Ayati; Hassan Jamshidian; Amir Arbab; Hamidreza Ghorbani; Erfan Amini; Hassan Hakima; Sohrab Salehi; Alireza Ghadian
Journal:  Nephrourol Mon       Date:  2015-03-20

2.  Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.

Authors:  Liang Wang
Journal:  World J Radiol       Date:  2009-12-31

3.  Zinc intake from supplements and diet and prostate cancer.

Authors:  Alejandro Gonzalez; Ulrike Peters; Johanna W Lampe; Emily White
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

4.  Does prostate specific antigen density correlates with aggressiveness of the prostate cancer?

Authors:  S Saidi; V Georgiev; S Stavridis; D Petrovski; S Dohcev; L Lekovski; Z Popov; S Banev; G Spasovski
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

5.  The Serum Levels of Trace Metals in Nigerian Males with Different PSA Values.

Authors:  Arinola Olatunbosun Ganiyu; Charles Davies Ayebatonyo Mabel
Journal:  Malays J Med Sci       Date:  2008-04

6.  The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.

Authors:  Yuan Zhou; Han Guan; Yong Fu; Likai Mao; Jiyue Ge; Lutan Liu; Lei Cheng; Chao Guan
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients.

Authors:  Yu-Jun Chang; Wen-Miin Liang; Hsi-Chin Wu; Hsueh-Chun Lin; Jong-Yi Wang; Tsai-Chung Li; Yi-Chun Yeh; Chih-Hung Chang
Journal:  Health Qual Life Outcomes       Date:  2012-08-20       Impact factor: 3.186

8.  CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men.

Authors:  Guangbo Fu; Jialin Tang; Meilin Wang; Chao Qin; Fu Yan; Qi Ding; Changjun Yin; Xinru Wang; Zhengdong Zhang
Journal:  J Biomed Res       Date:  2011-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.